TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading.

Autor: Xu Y; Huffington Center on Aging, Baylor College of Medicine, Houston, TX, USA. Yin.Xu@bcm.edu., Du S; Huffington Center on Aging, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Marsh JA; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA., Horie K; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA., Sato C; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA., Ballabio A; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.; Dan and Jan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli (Naples), Italy.; Department of Medical and Translational Sciences, Federico II University, Naples, Italy., Karch CM; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.; Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA., Holtzman DM; Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.; Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA., Zheng H; Huffington Center on Aging, Baylor College of Medicine, Houston, TX, USA. huiz@bcm.edu.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. huiz@bcm.edu.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. huiz@bcm.edu.
Jazyk: angličtina
Zdroj: Molecular psychiatry [Mol Psychiatry] 2021 Oct; Vol. 26 (10), pp. 5925-5939. Date of Electronic Publication: 2020 May 04.
DOI: 10.1038/s41380-020-0738-0
Abstrakt: Neurofibrillary tangles (NFTs) composed of hyperphosphorylated and misfolded tau protein are a pathological hallmark of Alzheimer's disease and other tauopathy conditions. Tau is predominantly an intraneuronal protein but is also secreted in physiological and pathological conditions. The extracellular tau has been implicated in the seeding and propagation of tau pathology and is the prime target of the current tau immunotherapy. However, truncated tau species lacking the microtubule-binding repeat (MTBR) domains essential for seeding have been shown to undergo active secretion and the mechanisms and functional consequences of the various extracellular tau are poorly understood. We report here that the transcription factor EB (TFEB), a master regulator of lysosomal biogenesis, plays an essential role in the lysosomal exocytosis of selected tau species. TFEB loss of function significantly reduced the levels of interstitial fluid (ISF) tau in PS19 mice expressing P301S mutant tau and in conditioned media of mutant tau expressing primary neurons, while the secretion of endogenous wild-type tau was not affected. Mechanistically we found that TFEB regulates the secretion of truncated mutant tau lacking MTBR and this process is dependent on the lysosomal calcium channel TRPML1. Consistent with the seeding-incompetent nature of the truncated tau and supporting the concept that TFEB-mediated lysosomal exocytosis promotes cellular clearance, we show that reduced ISF tau in the absence of TFEB is associated with enhanced intraneuronal pathology and accelerated spreading. Our results support the idea that TFEB-mediated tau exocytosis serves as a clearance mechanism to reduce intracellular tau under pathological conditions and that effective tau immunotherapy should devoid targeting these extracellular tau species.
(© 2020. The Author(s), under exclusive licence to Springer Nature Limited.)
Databáze: MEDLINE